We are live on ! Find out more
ZBH icon

Zimmer Biomet

95.36 USD
+1.11
1.18%
At close Updated Sep 18, 4:00 PM EDT
Pre-market
After hours
96.44
+1.08
1.13%
1 day
1.18%
5 days
0.12%
1 month
-3.82%
3 months
8.4%
6 months
7.05%
Year to date
5.93%
1 year
-4.84%
5 years
-31.81%
10 years
-21.4%
 

About: Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Employees: 17,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 52%
Neutral 48%
Negative 0%
Positive
Zacks Investment Research
1 day ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Neutral
PRNewsWire
10 days ago
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and Data WARSAW, Ind.
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Positive
Zacks Investment Research
14 days ago
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Positive
Seeking Alpha
17 days ago
Zimmer Biomet - Showing Signs Of Life
Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.
Zimmer Biomet - Showing Signs Of Life
Positive
Zacks Investment Research
18 days ago
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
Neutral
PRNewsWire
21 days ago
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
Neutral
Zacks Investment Research
29 days ago
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
Positive
Zacks Investment Research
1 month ago
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock
Neutral
MarketBeat
1 month ago
Zimmer Biomet Q2 Earnings Call Highlights
Zimmer Biomet NYSE: ZBH reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a reported basis and 4.0% on an organic constant-currency basis, as growth in hips, specialty businesses and technology helped offset weaker performance in certain other product lines.
Zimmer Biomet Q2 Earnings Call Highlights
Positive
Zacks Investment Research
1 month ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Price charts implemented using Lightweight Charts™